Cureus . First Case of Autoimmune Hemolytic Anemia Associated With COVID-19 Infection in Sri Lanka: A Case Report

[tetano]

Cureus


. 2021 Oct 29;13(10):e19118.
doi: 10.7759/cureus.19118. eCollection 2021 Oct.
First Case of Autoimmune Hemolytic Anemia Associated With COVID-19 Infection in Sri Lanka: A Case Report


Vaishnavi Arunpriyandan ¹ , Somasuriyam Kumanan ¹ , Mayurathan Pakkiyaretnam ¹



Affiliations

• PMID: 34868764
• PMCID: PMC8627640
• DOI: 10.7759/cureus.19118

Abstract

Autoimmune hemolytic anemia (AIHA) is a condition characterized by the increased destruction of red blood cells (RBCs) mediated by anti-erythrocyte autoantibodies with or without complement activation. Its clinical presentation is heterogeneous, ranging from asymptomatic to severe forms with fatal outcomes, and it can be either idiopathic or secondary to a coexisting disorder. In this report, we present a case of a patient who suffered from her first episode of acute and severe AIHA during Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2) and responded well with the treatment.

Keywords: autoimmune hemolytic anemia; covid-19; immune-mediated hemolysis; steroids; warm autoimmune hemolytic anemia.